Clinical Trial Update: A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating fesoterodine in patients with overactive bladder who had insufficient response to tolterodine; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Urinary Bladder, Overactive | Phase 4 | Status: COMPLETED | Results posted: 2013-03-12